Women's Health Devices Market Size, Share, Growth Analysis, By Application (General Health & Wellness, Cancers & Other Chronic Diseases), By End-User (Hospitals, Clinics), By Region - Industry Forecast 2025-2032

Global Women's Health Devices Market size was valued at USD 40.2 billion in 2023 and is poised to grow from USD 42.13 billion in 2024 to USD 61.3 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

Regarding the women's health devices market's competitive environment, there are numerous businesses of varying sizes present, each with a varied product portfolio and a broad range of potential applications. F. Hoffmann-La Roche Ltd. currently holds a dominant position in the market, mostly as a result of the company's diagnostics portfolio, which includes several products that address female health issues. Numerous female cancers, as well as pregnancy and fertility, are some of the application areas of women's health that F. Hoffmann-La Roche Ltd. handles. Boston Scientific Corporation is another significant competitor with a big array of medical devices for pelvic health. 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Boston Scientific Corporation (United States) ', 'Abbott Laboratories (United States) ', 'Koninklijke Philips N.V. (Netherlands) ', 'CooperSurgical Inc. (United States) ', 'Caldera Medical Inc. (United States) ', 'Medtronic plc (Ireland) ', 'Johnson & Johnson (United States) ', 'GE HealthCare Technologies Inc. (United States) ', 'Siemens Healthineers AG (Germany) ', 'Cardinal Health Inc. (United States) ', 'Becton, Dickinson and Company (United States) ', 'Olympus Corporation (Japan) ', 'Fujifilm Holdings Corporation (Japan) ', 'Stryker Corporation (United States) ', 'Zimmer Biomet Holdings Inc. (United States) ', 'Smith & Nephew plc (United Kingdom) ', 'Intuitive Surgical Inc. (United States) ', 'Merck & Co. (United States) ', 'Hologic, Inc. (United States)'

Due to the significant increase in the number of female patients over the past several years, there has been a significant rise in the need for medical equipment for the diagnosis and treatment of diseases affecting women's health, such as a variety of female cancers. Numerous studies have shown that during the past few decades, there has been a marked rise in the prevalence of disorders affecting women's health. Several governments have launched projects to increase knowledge of female ailments to lower the mortality rate among female patients with serious illnesses.

Numerous investment initiatives are being made, which is one of the most common trends in the women's health devices market and is expected to significantly boost market growth throughout the projected period. There are a lot of benefits of aggressive investment programs. Several of the benefits of these initiatives increase the number of more practical and cheap solutions available, which encourages the widespread use of these medical devices. Additionally, these investment opportunities are anticipated to lead to the introduction of cutting-edge products.

North America dominated the global women's health devices market, with a market value of US$ 15.40 billion in 2021 and is likely to continue to do so during the forecast period. A few of the factors that contribute to this region's dominance include the substantial healthcare spending on women's health in the area and the comparably larger demand for technologically advanced devices.